Ascendis Pharma A/S annual gross margin
2019
2020
2021
2022
2023
2024
2025
Ascendis Pharma A/S's gross margin was 86.82% for fiscal 2025.
View full Ascendis Pharma A/S company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 86.82% | −1.01 pp |
| 2024 | 2024-12-31 | 87.83% | +4.47 pp |
| 2023 | 2023-12-31 | 83.36% | +7.07 pp |
| 2022 | 2022-12-31 | 76.28% | +21.58 pp |
| 2021 | 2021-12-31 | 54.71% | −45.29 pp |
| 2020 | 2020-12-31 | 100.00% | 0.00 pp |
| 2019 | 2019-12-31 | 100.00% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | 90.47% | −1.47 pp |
| Q3 2025 | 2025-09-30 | 89.54% | +8.90 pp |
| Q2 2025 | 2025-06-30 | 80.10% | +11.95 pp |
| Q1 2025 | 2025-03-31 | 82.65% | −9.46 pp |
| Q4 2024 | 2024-12-31 | 91.94% | +6.07 pp |
| Q3 2024 | 2024-09-30 | 80.63% | −3.99 pp |
| Q2 2024 | 2024-06-30 | 68.15% | −4.57 pp |
| Q1 2024 | 2024-03-31 | 92.11% | +5.86 pp |
| Q4 2023 | 2023-12-31 | 85.87% | +8.20 pp |
| Q3 2023 | 2023-09-30 | 84.62% | −4.31 pp |
| Q2 2023 | 2023-06-30 | 72.72% | −9.65 pp |
| Q1 2023 | 2023-03-31 | 86.24% | +48.43 pp |
| Q4 2022 | 2022-12-31 | 77.67% | +49.61 pp |
| Q3 2022 | 2022-09-30 | 88.93% | −11.07 pp |
| Q2 2022 | 2022-06-30 | 82.37% | −17.63 pp |
| Q1 2022 | 2022-03-31 | 37.81% | −62.19 pp |
| Q4 2021 | 2021-12-31 | 28.06% | — |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 100.00% | — |
| Q1 2021 | 2021-03-31 | 100.00% | — |
Over the last five reported fiscal years, Ascendis Pharma A/S's gross margin decreased from 100.00% to 86.82%, a change of −13.18 percentage points. The latest reported quarter, Q4 2025, shows 90.47%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ascendis Pharma A/S filings at SEC.gov ↗